The University of Pittsburgh - Of The Commonwealth System Of Higher Education, doing business as The University of Pittsburgh, has been awarded multiple federal contract delivery orders from the Department of the Army Medical Command and the Defense Health Agency. These contracts, which do not utilize any set-aside designations, support the University's research capabilities in biomedical sciences, clinical studies, and defense-related technologies.
The delivery orders include the "CAVALIER Trial" to evaluate prehospital resuscitation methods ($11,999,380), the "DSUVIA Early Evaluation of Pain Trial" to assess a new opioid analgesic ($3,315,417), the "LITES Standalone Network" to provide information technology services ($7,874,223), and several clinical trials focused on topics like trauma care, hemorrhagic shock, and pain management ($5,529,830 to $13,634,194). The periods of performance for these contracts range from 2019 to 2026, with the overall Indefinite Delivery/Indefinite Quantity contract with the Department of the Army Medical Command having a potential value up to $112 million. Through these federal contracts, the University of Pittsburgh leverages its expertise in medical research, academic affiliation, and collaboration with other institutions to support the Army Medical Command's healthcare mission and the Defense Health Agency's medical readiness objectives.
Generated 6/2/24, 12:01 AM